Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small-molecule correctors and stabilizers to target p53
Maryam M.J. Fallatah, Fiona V. Law, Warren Chow, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 5, pp. 274-289
Open Access | Times Cited: 20

Showing 20 citing articles:

An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer
Lingping Kong, Fanlu Meng, Ping Zhou, et al.
Science Bulletin (2024) Vol. 69, Iss. 13, pp. 2122-2135
Open Access | Times Cited: 8
p53 lysine-lactylated modification contributes to lipopolysaccharide-induced proinflammatory activation in BV2 cell under hypoxic conditions
Xuechao Fei, Lu Chen, Jiayue Gao, et al.
Neurochemistry International (2024) Vol. 178, pp. 105794-105794
Closed Access | Times Cited: 6
Computational advances in discovering cryptic pockets for drug discovery
Martijn P. Bemelmans, Zoe Cournia, Kelly L. Damm‐Ganamet, et al.
Current Opinion in Structural Biology (2025) Vol. 90, pp. 102975-102975
Open Access
Small molecules that targeting p53 Y220C protein: mechanisms, structures, and clinical advances in anti-tumor therapy
Jinglei Xu, Jiahao Yuan, W. Wang, et al.
Molecular Diversity (2025)
Closed Access
Structural and functional analysis of cancer-associated missense variants in the retinoblastoma protein (Rb) pocket domain
Anthony E. Castro, Alfredo Ruiz-Rivera, Chad C Moorman, et al.
Journal of Biological Chemistry (2025), pp. 108284-108284
Open Access
Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma
Wanxian Chen, Linsa Zhou, Jingjing Jiang, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levels
Beatrice Tosoni, Eisa Naghshineh, Irene Zanin, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 4
Open Access
AI-powered discovery of a novel p53-Y220C reactivator
Shan Zhou, Dafei Chai, Xu Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
The Role of p53 in Nanoparticle-Based Therapy for Cancer
Olga Szewczyk‐Roszczenko, Nikolai A. Barlev
Cells (2023) Vol. 12, Iss. 24, pp. 2803-2803
Open Access | Times Cited: 6
Pyrimidine Triones as Potential Activators of p53 Mutants
Maryam M.J. Fallatah, Özlem Demir, Fiona V. Law, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 967-967
Open Access | Times Cited: 1
BH3-mimetics or DNA-damaging agents in combination with RG7388 overcome p53 mutation-induced resistance to MDM2 inhibition
Nikolay V. Pervushin, Dmitry K. Nilov, Sergey V. Pushkarev, et al.
APOPTOSIS (2024)
Open Access | Times Cited: 1
FGF12 Positively Regulates Keratinocyte Proliferation by Stabilizing MDM2 and Inhibiting p53 Activity in Psoriasis
Nan Wang, Xiejun Xu, Fangqian Guan, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 1
Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations
Dina Hesham, Jotaro On, Nouran Alshahaby, et al.
Journal of Neuro-Oncology (2024)
Closed Access
Establishment and characterization of a novel hypopharyngeal squamous cell carcinoma cell line CZH1 with genetic abnormalities
Jingyu Ma, Xiaoke Zhu, Yu Heng, et al.
Human Cell (2024) Vol. 37, Iss. 2, pp. 546-559
Closed Access
Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023
Wen Hou, Xinliang Xu, Lejun Huang, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access
Library screening identifies commercial drugs as potential structure correctors of abnormal apolipoprotein A-I
Christina Gkolfinopoulou, Angeliki Bourtsala, Daphne N. Georgiadou, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 5, pp. 100543-100543
Open Access
PhaSeDis: A Manually Curated Database of Phase Separation–Disease Associations and Corresponding Small Molecules
Taoyu Chen, Guoguo Tang, Tianhao Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Targeting Hdm2 and Hdm4 in Anticancer Drug Discovery: Implications for Checkpoint Inhibitor Immunotherapy
Monde Ntwasa
Cells (2024) Vol. 13, Iss. 13, pp. 1124-1124
Open Access
Covalent Modification of p53 by (E)-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one
Katie M. Brown, Marco Robello, Andrew J. Perciaccante, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 11, pp. 3559-3572
Open Access
Identification of p53-R175H Q167 and R248 as Residues Most Involved in Its Interaction with Plakoglobin
Chu Shiun Lo, Sara Ibrahim Omar, Jinlan Chang, et al.
Re GEN Open (2023) Vol. 3, Iss. 1, pp. 40-51
Open Access | Times Cited: 1
Page 1

Scroll to top